Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PostEra leverages its proprietary Proton AI/ML platform to accelerate the design, synthesis, and optimization of small molecule drug candidates. The company has demonstrated rapid progress in both wholly owned preclinical programs—primarily in women’s health/fertility—and through high-profile co-discovery partnerships with major pharmaceutical companies such as Pfizer and Amgen. It played a leading role in the COVID Moonshot initiative. No clinical-stage results have been published as of May 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PostEra.